Abstract:Obesity is often associated with reduced plasma insulin-like growth factor 1 (IGF-1) levels, oxidative stress, mitochondrial damage, and cardiac dysfunction. This study was designed to evaluate the impact of IGF-1 on high-fat diet–induced oxidative, myocardial, geometric, and mitochondrial responses. FVB and cardiomyocyte-specific IGF-1 overexpression transgenic mice were fed a low- (10%) or high-fat (45%) diet to induce obesity. High-fat diet feeding led to glucose intolerance, elevated plasma levels of leptin, interleukin 6, insulin, and triglyceride, as well as reduced circulating IGF-1 levels. Echocardiography revealed reduced fractional shortening, increased end-systolic and end-diastolic diameter, increased wall thickness, and cardiac hypertrophy in high-fat–fed FVB mice. High-fat diet promoted reactive oxygen species generation, apoptosis, protein and mitochondrial damage, reduced ATP content, cardiomyocyte cross-sectional area, contractile and intracellular Ca2+ dysregulation (including depressed peak shortening and maximal velocity of shortening/relengthening), prolonged duration of relengthening, and dampened intracellular Ca2+ rise and clearance. Western blot analysis revealed disrupted phosphorylation of insulin receptor and postreceptor signaling molecules insulin receptor substrate 1 (tyrosine/serine phosphorylation), Akt, glycogen synthase kinase 3&bgr;, forkhead transcriptional factors, and mammalian target of rapamycin, as well as downregulated expression of mitochondrial proteins peroxisome proliferator-activated receptor-&ggr; coactivator 1&agr; and uncoupling protein 2. Intriguingly, IGF-1 mitigated high-fat–diet feeding-induced alterations in reactive oxygen species, protein and mitochondrial damage, ATP content, apoptosis, myocardial contraction, intracellular Ca2+ handling, and insulin signaling but not whole body glucose intolerance and cardiac hypertrophy. Exogenous IGF-1 treatment also alleviated high-fat diet–induced cardiac dysfunction. Our data revealed that IGF-1 alleviates high-fat diet–induced cardiac dysfunction despite persistent cardiac remodeling, possibly because of preserved cell survival, mitochondrial function, and insulin signaling.

Insulin-Like Growth Factor I Prevents Cellular Aging via Activation of Mitophagy

Insulin-like Growth Factor-1 Regulates the SIRT1-p53 Pathway in Cellular Senescence.

Deficiency of insulin-like growth factor 1 attenuates aging-induced changes in hepatic function: role of autophagy.

Cardiac-specific Overexpression of Insulin-Like Growth Factor 1 Attenuates Aging-Associated Cardiac Diastolic Contractile Dysfunction and Protein Damage.

Influence of Cardiac-Specific Overexpression of Insulin-Like Growth Factor 1 on Lifespan and Aging-Associated Changes in Cardiac Intracellular Ca2+ Homeostasis, Protein Damage and Apoptotic Protein Expression.

Deficiency of Insulin-Like Growth Factor 1 Reduces Sensitivity to Aging-Associated Cardiomyocyte Dysfunction

IGF-1 Induces Cellular Senescence in Rat Articular Chondrocytes Via Akt Pathway Activation

Insulin-like growth factor-1 attenuates oxidative stress-induced hepatocyte premature senescence in liver fibrogenesis via regulating nuclear p53–progerin interaction

IGF-1 Signaling Regulates Mitochondrial Remodeling during Myogenic Differentiation

Isthmin-1 Improves Aging-Related Cardiac Dysfunction in Mice through Enhancing Glycolysis and SIRT1 Deacetylase Activity

IGF-1 Potentiates Sensory Innervation Signalling by Modulating the Mitochondrial Fission/fusion Balance

Mitophagy as a guardian against cellular aging

Spermidine overrides INSR (insulin receptor)-IGF1R (insulin-like growth factor 1 receptor)-mediated inhibition of autophagy in the aging heart

IGF2 deficiency promotes liver aging through mitochondrial dysfunction and upregulated CEBPB signaling in D-galactose-induced aging mice

Insulin-like Growth Factor-1 Receptor Activation Prevents Hydrogen Peroxide-Induced Oxidative Stress, Mitochondrial Dysfunction and Apoptosis

Role of Insulin-Like Growth Factor-1 (IGF-1) in Regulating Cell Cycle Progression

The Insulin-like Growth Factor System and Aging

IGF-1 Has Sexually Dimorphic, Pleiotropic, and Time-Dependent Effects on Healthspan, Pathology, and Lifespan.

Effects of GH/IGF on the Aging Mitochondria

Insulin-Like Growth Factor 1 Alleviates High-Fat Diet-Induced Myocardial Contractile Dysfunction: Role of Insulin Signaling and Mitochondrial Function.

IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice